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Abstract
Background: At present, nothing is known of the role of miRNAs in the immune response in vivo
despite the fact that inflammation is thought to underlie multiple acute and chronic diseases. In
these circumstances, patients are commonly treated with corticosteroids such as dexamethasone.
Results: To address this question, we have examined the differential expression of 104 miRNAs
using real-time PCR during the innate immune response in mouse lung following exposure to
aerosilised lipopolysaccharide (LPS). Following challenge, we observed rapid and transient increase
in both the mean (4.3-fold) and individual levels of miRNA expression (46 miRNAs) which peaked
at 3 hrs. Crucially, this increase was correlated with a reduction in the expression of tumour
necrosis factor (TNF)-α, keratinocyte-derived chemokine (KC) and macrophage inflammatory
protein (MIP)-2, suggesting a potential role for miRNAs in the regulation of inflammatory cytokine
production. Examination of the individual miRNA expression profiles showed time dependent
increases in miR-21, -25, -27b, -100, 140, -142-3p, -181c, 187, -194, -214, -223 and -224.
Corticosteroid studies showed that pre-treatment with dexamethasone at concentrations that
inhibited TNF-α production, had no effect either alone or upon the LPS-induced miRNA
expression profile.
Conclusion: We have shown that the LPS-induced innate immune response is associated with
widespread, rapid and transient increases in miRNA expression in the mouse lung and we speculate
that these changes might be involved in the regulation of the inflammatory response. In contrast,
the lack of effect of dexamethasone in either control or challenged animals implies that the actions
of glucocorticoids per se are not mediated through changes in miRNAs expression and that LPS-
induced increases in miRNA expression are not mediated via classical inflammatory transcription
factors.
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Background
RNA interference (RNAi), mediated by 19- to 23- nucle-
otide double stranded RNA, has been identified as an evo-
lutionarily conserved mechanism for the post-
transcriptional regulation of mammalian gene expression
[1]. Initial studies implicated RNAi in the cellular
response to viral infection following the demonstration
that virally-derived double stranded RNA was cleaved by
the action of the RNase-III-type enzyme Dicer, to produce
the characteristic RNA duplexes. These were called short
interference RNA (siRNA) in order to differentiate them
from longer double stranded RNA (> 30 nucleotide
duplexes) that induced an interferon-mediated anti-viral
response. The biological action of siRNAs is mediated via
the RNA-induced silencing complex (RISC) that utilises
the guide strand as a template to cleave the complemen-
tary mRNA sequence and attenuate subsequent protein
production [2].
Significantly, recent studies have also identified the exist-
ence of endogenous genes that are converted to siRNA-
like molecules, entitled microRNAs (miRNA) [3,4]. These
genes are transcribed by RNA polymerase II [5,6], proc-
essed by the RNase III enzyme Drosha in combination
with DGCR8 to produce a hairpin RNA of ~65-nucle-
otides [7] before being exported into the cytoplasm by
exportin 5 [8]. Like siRNAs, these pre-miRNAs are then
cleaved by Dicer to produce 19- to 23-nucleotide RNA
duplexes, which are incorporated into a RISC-like com-
plex. However, although miRNAs are also able to induce
mRNA cleavage [9,10], they are believed to predominately
block either mRNA translation or promote degradation
following imperfect complementary binding of the guide
sequence to miRNA-recognition elements (MRE) within
the 3' untranslated region (UTR) of target genes [11-15].
Significantly, within the guide strand the specificity is
thought to be primarily mediated by the 'seed' region
localised at residues 2–8 at the 5' end [16] although recent
studies have shown that their biological activity is influ-
enced by a number of additional factors including the
number of MRE binding sites [17], the distance between
MRE binding sites [18] and the higher order structure of
the target mRNA [19].
Although nearly 500 miRNAs have been identified in rats,
mice and humans their physiological role is still uncertain
[20,21]. As a result of the redundancy within the 'seed'
region, predictive algorithms have suggested that up to a
third of all genes may contain putative single or multiple
MREs and might therefore be regulated by changes in
miRNA expression [22]. Early functional studies have
demonstrated a role for miRNAs in apoptosis/prolifera-
tion [23,24], development [25-27], insulin secretion [28]
and cholesterol metabolism [29,30] whilst differential
expression studies have shown a possible role in multiple
cancers [31,32].
The innate immune response mediated by epithelial cells
and immune cells such as macrophages, neutrophils and
dendritic cells, is the first line of defence against infection.
This response involves the recognition of conserved
molecular patterns upon the invading micro-organism,
entitled pathogen-associated molecular patterns
(PAMPs), by members of the Toll-like receptor (TLR) fam-
ily. At present, eleven members of the TLR family have
been identified, including TLR-4 which recognises
lipopolysaccharide (LPS) derived from gram negative bac-
teria. Importantly, exposing animals to LPS has been
shown to stimulate a host of responses including the
release of pro-inflammatory chemokines and cytokines
[33,34] which is mediated through activation of intracel-
lular signalling pathways involving TRAF-6/IRAK-1 and
recruitment of pro-inflammatory transcription factors
such as nuclear factor (NF)-κB and activator protein (AP)-
1 [35,36].
Glucocorticoids are commonly used to treat the inflam-
mation associated with many acute and chronic diseases
including asthma, rheumatoid arthritis, auto-immunity,
psoriasis and multiple sclerosis. Under resting conditions,
the glucocorticoid receptor (GR) is localised within the
cytoplasm bound to a number of accessory proteins such
as heat shock protein (hsp)-90 and peptidyl-prolyl iso-
merases known as FK-binding proteins. However, follow-
ing binding of the GR receptor to glucocorticoids such as
dexamethasone, these accessory proteins are released and
the ligand-receptor complex translocates into the nucleus.
Once there, the GR forms into a homodimer, binds to glu-
cocorticoid responsive elements (GRE) within genomic
DNA, leading to an increase (trans-activation) in the
expression of anti-inflammatory genes or, less commonly,
repression of inflammatory genes (cis-repression). At
present,  cis-repression is thought to be unlikely to be
responsible for the widespread anti-inflammatory
response since it has been observed only at high glucocor-
ticoid concentrations. Instead, the actions of glucocorti-
coids are believed to be primarily mediated through the
inhibition of the pro-inflammatory transcription factors,
NF-κB and AP-1. This process, entitled trans-repression,
occurs following both protein-protein interactions
between the GR and the individual transcription factors,
as well as modulation of chromatin structure [36,37].
Little is known of the role of miRNAs in the innate
immune response although recent reports have shown
that this is associated with increased miR-146 and miR-
155 expression in monocytic cell lines and murine macro-
phages [38,39]. Interestingly, since two of the predicted
targets for miR-146, TRAF6 and IRAK1 are known to beBMC Genomics 2007, 8:240 http://www.biomedcentral.com/1471-2164/8/240
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involved in LPS signalling, these authors speculate that
miR-146 might regulate inflammation via a classical neg-
ative feedback pathway [39]. However, cell based studies
often differ significantly from the in vivo milieu, which
involves the interaction of multiple cell types. For this rea-
son, we have examined the profile of miRNA expression
during the innate immune response in mouse lung fol-
lowing aerosilised LPS challenge. In agreement with the
report of Taganov et al [39], we observed a rapid increase
in the profile of miRNA expression and showed that this
correlated with the resolution of inflammation. Further-
more, we demonstrate that the actions of glucocorticoids,
which are known to potently inhibit the LPS-induced
inflammatory response [40,41], are mediated at the tran-
scriptional level and not through changes in miRNA
expression.
Results and discussion
LPS induces an acute inflammatory response in mouse lung
To investigate the role of miRNAs in the mechanisms of
the innate immune response in vivo, we employed a LPS-
induced model of murine lung inflammation [42]. Expo-
sure of BALB/c mice to aerosolised LPS led to an immedi-
ate and dramatic increase in the airway concentration of
the pro-inflammatory cytokines and chemokines, TNF-α,
KC (the mouse equivalent of IL-8) and MIP-2, as deter-
mined in bronchoalveolar lavage (BAL) fluid (Figure 1A–
C). In all cases, this response peaked at approximately 1 hr
before dropping to essentially baseline levels at 6 – 12 hrs.
Examination of the recruitment of inflammatory cells into
the airways showed that this lagged behind the release of
inflammatory mediators. Thus, an increase in total cell
numbers in the bronchoalveolar lavage (BAL) was first
seen at 3 hrs (Figure 1D) whilst differential cell counts
showed that this increase was mainly attributable to neu-
trophil recruitment (Figure 1E).
miRNA expression profile following LPS challenge
From the profile of cytokine release, it appeared that we
might determine a role for miRNAs in the LPS-induced
innate immune response by measuring mature miRNA
levels in the lung tissue over 6 hrs. To this end, the time-
dependent changes in the miRNA expression profile in
RNA purified from whole mouse lung at 1 hr, 3 hrs and 6
hrs were measured using a novel RT-PCR based approach
[43]. To account for RNA loading, all samples were nor-
malised to 18S whilst changes in expression levels were
expressed as a fold-difference to time-matched controls in
which animals were exposed to aerosolised saline. Among
the 156 assays available no appreciable target detection
(Ct >38) occurred with the negative controls (cel-miR2,
cel-lin-4, ath-miR-159a) or with 13 miRNAs not predicted
to exist in mouse according to the Sanger Institute miRNA
registry version 7.1 [20,21]. Of the remainder 140 assays,
36 were found to express at a low levels (Ct >30), a feature
associated with intermittent loss of exponential PCR
product increase which we deemed inappropriate for reli-
able relative quantification. The order of expression of the
remaining 104 miRNAs according to ΔCt is shown in
Table S1.
Exposure to aerosolised LPS resulted in a general elevation
in mature miRNA levels at all time points. Examination of
the mean increase among all 104 miRNAs (Figure 2), an
hierarchically clustered (average linkage) heat map of the
miRNA expression profile (Figure 3), as well as the indi-
vidual miRNAs that were significantly up-regulated (Table
1), showed that this response was time-dependent and
peaked at 3 hrs. Thus, the average fold increase above the
time-matched saline controls was 2.39 ± 0.23, 4.27 ± 0.33
and 2.37 ± 0.25 at 1 hr, 3 hrs and 6 hrs, respectively (Fig-
ure 2). Since little is known of the functional role of miR-
NAs and given the limitations of the programmes that
predict miRNA targets, unlike mRNA expression data,
cluster analysis is unlikely to provide reliable information
on the potential mechanism of action of miRNA in LPS
induced inflammatory response. However, examination
of those miRNAs that were significantly up-regulated (p <
0.01) identified 11 miRNAs that were increased at 1 hr,
with a peak of 46 miRNAs at 3 hrs which then dropped to
21 miRNAs at 6 hrs (see additional Table S2). Interest-
ingly, in contrast to previous studies that have tended to
take a 'snapshot' of miRNA expression by investigating a
single time point, these transient changes in the miRNA
levels suggest that there is rapid turnover of miRNAs in
vivo. Although we are presently examining their functional
role, a comparison of the time course in miRNA expres-
sion and cytokine production leads us to speculate that
individual miRNAs might be involved in the resolution
rather than the induction of inflammation: the peak in the
lung tissue mature miRNA levels at 3 hrs coincides with
the drop in production of BAL and tissue TNF-α, KC and
MIP-2 (Figure 1). It could be postulated that these time-
dependent increases are caused by vasodilation, increased
blood flow and neutrophil migration, however this seems
unlikely given that the miRNA increases are seen at 1 hr
despite the absence of leukocyte infiltration and miRNAs
are decreased at 6 hrs even though neutrophil levels are
still elevated (Figure 1D/E).
In contrast to previous cell based studies [39] that showed
up-regulation of only 3 miRNAs (miR-132, miR-146 and
miR-155) following LPS stimulation of the monocytic
THP-1 cell line, we observed LPS-induced expression of
46 miRNAs at 3 h. Although these differences could be
related to the sensitivity of the methodology used to
measure miRNA levels, we believe that this is most likely
ascribable to the differences between the in vitro and in
vivo milieus. Thus, the lung contains multiple cell typesBMC Genomics 2007, 8:240 http://www.biomedcentral.com/1471-2164/8/240
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and exposure to LPS is known to activate a range of intra-
cellular and extracellular pathways.
In an attempt to identify individual miRNAs that might be
involved in the innate immune response, we found 12
miRNAs whose expression was increased in a time-
dependent fashion. From Figure 4, it can be seen that miR-
21, -25, -27b, -100, 140, -142-3p, -181c, 187, -194, -214
and -224 were significantly up-regulated at two time
points whilst the level of miR-223 was significantly
increased at 1, 3 and 6 h. Unlike the LPS-induced response
in THP-1 cells and mouse macrophages, we failed to
observe up-regulation of miRNA-146 or -155 [38,39]. The
reasons behind these differences are presently unknown
although they could be a result of multiple factors includ-
ing the presence of multiple cell types within the lung or
be related to the dynamics of the two models. Thus, com-
pared to cell culture models, lungs are likely to be exposed
to lower LPS doses over shorter time periods. Future stud-
ies might therefore measure miRNA-146 and miRNA-155
expression during chronic inflammatory responses and/or
at doses that result in lung injury.
To confirm the results obtained with RT-PCR and deter-
mine the distribution of miRNA expression in the
inflamed mouse lung, we examined the expression of
miRNA-223 using in situ hybridisation since this was the
only miRNA that was significantly up-regulated at all time
points. From Figure 5, it can be seen that we observed a
prominent increase in miRNA-223 expression in alveolar
and bronchial epithelial cells at 3 h following exposure to
aerosilised LPS. Furthermore, we observed the migration
of inflammatory cells into the bronchioles, most probably
neutrophils, which are also stained for miRNA-223. Inter-
estingly, the LPS-induced increases appear to be cell type-
specific since we observed very limited changes in miRNA-
233 expression within vascular endothelial cells.
Effect of dexamethasone upon the profile of miRNA 
expression
To investigate further the role of miRNAs in the innate
immune response, it was decided to examine the effect of
treatment with dexamethasone, both alone and prior to
LPS challenge. As expected, administration of dexametha-
sone alone had no effect upon basal TNF-α production in
Time course of LPS-induced changes in BAL cytokines and cell infiltrates Figure 1
Time course of LPS-induced changes in BAL cytokines and cell infiltrates. Mice were exposed to aerosolised LPS and at the 
indicated time, the BAL levels of TNF-α (A), KC (B) MIP-2 (C), total leukocyte (D) and neutrophils (E) were determined. The 
values give are the mean ± SEM obtained from 6 mice.
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lung tissue (Figure 6A). However, pre-treatment with dex-
amethasome was found to inhibit LPS-induced increases
in the tissue and BAL TNF-α levels, as well as BAL neu-
trophils (Figure 6A–C). In contrast to LPS, examination of
the mature miRNA mean expression level (Figure 2) and
expression profile (Figure 3) following intraperitoneal
administration of dexamethasone alone showed no effect
at 1 hrs and 3 hrs post-saline aerosol challenge, but small
down-regulation of expression at 6 hrs. Investigation of
the extent of miRNA expression downregulation across
multiple time points failed to identify individual miRNAs
whose basal expression might be sensitive to GR-medi-
ated repression. However, the expression of 1 miRNA
(miR-139) and 10 miRNAs (miR-20, -34b, -154, -181c, -
187, -204, -296, -301, -340, and -342) were significantly
reduced at 3 h and 6 h, respectively.
Given the inhibition of the LPS-induced inflammatory
response by glucocorticoids, we ventured to examine
whether this might also be mediated through changes in
miRNA expression. From figures 2 and 3, it can be seen
that pre-treatment with dexamethasone had little effect
upon either the mean LPS-induced increases in miRNA
expression or the miRNA profile at 1 h and 3 h after aero-
solised LPS challenge. In contrast, as with dexamethasone
alone, there was a small reduction in overall miRNA
expression at 6 h (mean fold changes reduced from 2.36 ±
0.25 to 1.72 ± 0.07 (p < 0.001)). However, the fact that
this response was not observed until this extended time
point implies that these changes might be secondary to
the action of glucocorticoids upon the transcription of
protein-encoding genes. Once again we identified a
number of miRNAs whose expression appeared to be
repressed at a single time point including miR-187 (1 hrs),
miR-27b (6 h), miR-29c (6 h), miR-100 (6 h), miR-149 (6
h), miR-150 (6 h) and miR-154 (6 h) (Table S2). Only the
expression of miR-154 and miR-187 were found to be
inhibited by dexamethasone in both the absence and
presence of LPS stimulation. This lack of effect of dexam-
ethasone suggests that LPS-induced increases in miRNA
expression are not mediated through activation of pro-
inflammatory transcription factors, such as NF-κB and AP-
1, which are known to be inhibited by glucocorticoids.
Furthermore, since neutrophil migration was attenuated
in the presence of dexamethasone, this observation pro-
vides further evidence that inflammatory vascular changes
and cell migration do not contribute to the LPS-induced
changes in miRNA expression (Figure 4B).
Conclusion
In summary, we have used a novel RT-PCR based
approach to measure the differential mature miRNA
expression profile during the innate immune response to
aerosilised LPS in the mouse lung. Unlike previous stud-
ies, which have examined the role of miRNAs during
medium and long term responses such as apoptosis/pro-
liferation [23,24], development [25-27], insulin secretion
[28] and cholesterol metabolism [29,30], our studies have
shown that LPS induced rapid and transient changes in
lung miRNA expression and imply that endogenous RNAi
might regulate acute phenotypic responses. Although
these studies have not identified the functional role of the
individual miRNAs over-expressed during LPS-induced
lung inflammation, we speculate that a proportion might
be involved in the resolution of inflammatory cytokine
production since this increased miRNA expression is con-
comitant to the reduction in the levels of the pro-inflam-
matory mediators TNF-α, KC and MIP-2. Since the
resolution of inflammation is crucial to preventing tissue
damage, a range of mechanisms have evolved to regulate
this process including negative feedback inhibition of
intracellular pathways [42] and the release of anti-inflam-
matory mediators [44]. Significantly, this report suggests
that increased miRNA expression might provide an addi-
tional post-transcriptional mechanism for the regulation
of inflammation. Indeed, miRNA target prediction data-
bases employing algorithms based upon complementary
binding between the miRNA seed region and the miRNA
recognition elements within target mRNA 3' UTR identify
multiple targets for the miRNAs potentially involved in
inflammatory responses. However, at present it is difficult
to identify specific targets or a specific mechanism since a
Time-dependent changes in the overall miRNA expression  levels Figure 2
Time-dependent changes in the overall miRNA expression 
levels. Mice pre-treated intraperitoneally for 1 hr with either 
saline or dexamethasone, were challenged with either aero-
silised saline or LPS. At the indicated time, the mean ± SEM 
(n = 5) of the change in lung tissue levels for 104 mature 
miRNAs was determined relative to time-matched saline 
controls (equivalent to 1). Statistical significance was deter-
mined by ANOVA followed by Tukey's post-test where ** = 
p < 0.01 and *** = p < 0.001 versus saline and ### = p < 
0.001 for dexamethasone-LPS versus LPS-only treated ani-
mals.
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Hierarchically clustered (average linkage) heat map of the time course of LPS- and/or dexamethasone-induced changes in  miRNA expression in mouse lung tissue Figure 3
Hierarchically clustered (average linkage) heat map of the time course of LPS- and/or dexamethasone-induced changes in 
miRNA expression in mouse lung tissue. Mice were exposed to either aerosilised LPS, intraperitoneally administered dexame-
thasone or were pre-treated with dexamethasone (1 hr) prior to LPS challenge. At the indicated time points following LPS 
challenge, the levels of 104 mature miRNAs were determined using a TaqMan assay panel. The log2 transformants of the fold-
change in expression compared to time-matched saline controls are represented.
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number of recent publications have questioned the utility
of these algorithms and demonstrated that the biological
actions of miRNAs are also influenced by additional fac-
tors such as the number of MREs [17], the spacing
between MREs [19] and mRNA secondary structure [19].
Nonetheless, bioinformatic investigation of the 3' UTRs of
TNF-α, KC and MIP-2 predicts that only TNF-α might con-
tain MRE sites for miR-25 and miR-100 and implies that
miRNAs are unlikely to regulate the LPS-induced response
through direct action upon the mRNAs of these inflam-
matory mediators. Instead, as shown by the group of Bal-
timore  et al [39], it is more likely that any anti-
inflammatory actions of miRNAs are mediated through
negative feedback regulation of inflammatory signalling
pathways. Finally, to investigate the mechanism that pro-
motes LPS-induced miRNA over-expression we examined
the effect of the glucocorticoid dexamethasone. Our data
indicates that the anti-inflammatory actions of the gluco-
corticoid appear to be primarily mediated at the transcrip-
tional level since treatment with dexamethasone alone or
prior to LPS exposure had little effect upon the profile of
miRNA expression. Interestingly, the fact that dexametha-
sone had little effect upon the LPS-induced increases in
miRNA levels suggests that increased transcription of
miRNA genes is not mediated by pro-inflammatory tran-
scription factors such as NF-κB and AP-1.
Methods
Animal studies
Male BALB/c mice were obtained from Harlan UK (Bices-
ter, UK) and were allowed to acclimatise for a week prior
to use. Food and drink were provided ad libitum. All pro-
cedures carried out were performed in accordance with
the UK 1986 Animals (Scientific Procedures) Act. For
studies involving measurement of BAL cytokines and cel-
lular infiltrate, mice were orally dosed with 200 μl vol-
umes of vehicle (1% m/v carboxymethylcellulose, Sigma-
Aldrich, Poole, UK) or 1 mg/kg dexamethasone (Sigma-
Aldrich) in vehicle 0.5 hrs prior to LPS exposure. For stud-
ies of miRNA expression and lung tissue TNF-α, mice were
injected intra-peritoneally with 300 μl of either saline or 5
mg/kg dexamethasone in saline, 1 hr prior to aerosol
exposure. The mice were challenged with either aero-
solised saline or LPS (0.1 mg/ml, Escherichia coli serotype
0111:B4, Sigma) for 0.5 hrs using an Ultra-Neb 99 neb-
uliser (Sunrise Medical Ltd., Wollaston, UK). Animals
Time dependent, LPS-induced increases in mature miRNA expression levels Figure 4
Time dependent, LPS-induced increases in mature miRNA expression levels. At the indicated times, the levels of individual 
mature miRNAs were determined by TaqMan and were expressed as the fold change ± SEM (n = 5) compared to time-
matched saline controls (where saline controls are equivalent to 1). Statistical significance was determined by non-parametric 
ANOVA followed by Dunn's post-test where * p < 0.01 and ** p < 0.001.
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LPS-induced changes in miRNA-223 expression in the mouse lung Figure 5
LPS-induced changes in miRNA-223 expression in the mouse lung. Lungs were removed from saline-challenged (A-D) and LPS-
challenged (E-H) mice at 3 hrs post-challenge and tissue slices were examined by in situ hybridisation using either a miRNA-
223-specific (A, B, E, F) or scrambled (C, G) LNA probe, or histologically following cresyl violet staining (D, H). Bronchial (BE) 
and alveolar (AE) epithelia, as well as the vascular endothelium (VE) and leukocytes (L) are indicated.BMC Genomics 2007, 8:240 http://www.biomedcentral.com/1471-2164/8/240
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were sacrificed at set time-points post-challenge with an
intra-peritoneal injection of sodium pentobarbitone (200
mg/kg).
Bronchoalveolar lavage
Immediately following termination, the lungs were
exposed and the trachea was cannulated. Lungs were then
lavaged three times for 30 sec with 0.3 ml aliquots of
room-temperature sterile RPMI media (Invitrogen, Pais-
ley, UK) and the aliquots were pooled. Total and differen-
tial cell counts were performed and the levels of TNF-α,
KC and MIP-2 in the supernatant were measured using
mouse-specific, sandwich, enzyme-linked-immunosorb-
ent assay (ELISA) kits (R&D Systems UK, Oxfordshire,
UK), according to the manufacturer's instructions. Optical
densities were read on a microplate reader at 450 nm
(Spectromax PLUS, Molecular Devices, Sunnyvale, CA,
U.S.A.).
miRNA extraction and measurement
Following exposure to aerosilised LPS in the absence or
presence of dexamethasone, the left lobe was removed
into 1 ml of RNA later (Ambion Europe, Huntington, UK),
stored overnight at 4°C and then transferred to -20°C.
The right lobe was snap frozen in liquid nitrogen and
stored at -70°C prior to measurement of tissue TNF-α lev-
els. Total RNA extractions on the left lobe were carried out
using the mirVana™ miRNA isolation kit (Ambion
Europe) and an Ultraturrax T18 homogenizer according
to the manufacturer's instructions. RNA was eluted in 50
μl RNase-free water (Promega UK, Southampton, UK)
and stored at -70°C. RNA content and purity was meas-
ured in samples diluted 1/50 with RNase-free water using
a BioTek PowerWave XS (SSi Robotics, Tustin, CA, U.S.A.)
spectrophotometer (yield (± SD): 1.2 ± 0.4 mg/ml; purity
(A260/A280): 1.9 ± 0.1). miRNA expression profiling was
carried out on lung tissue total RNA extracts by two-step
Taqman® RT-PCR, normalised to 18S. Reverse transcrip-
tion was carried out on 5 ng of total RNA in 7.5 μl reac-
tions using the TaqMan® MicroRNA Reverse Transcription
Kit (Applied Biosystems, Warrington, UK) according to
the manufacturer's instructions [43]. In separate reactions,
random hexamers (Applied Biosystems) at a concentra-
tion of 10 μM were employed for 18S reverse transcrip-
tion, whereas miRNA-specific stem-loop primers available
in the Applied Biosystems Taqman® MicroRNA Assays,
Human Panel Early Access kit were used for target-specific
miRNA reverse transcription according to the manufac-
turer's instructions. Using an Applied Biosystems 7500
Real Time PCR System, 10 μl real time PCR reactions were
carried out on 0.7 μl of cDNA using TaqMan® Universal
PCR Master Mix, No AmpErase® UNG (Applied Biosys-
tems), Eukaryotic 18S rRNA Endogenous Control primer/
probe sets (Applied Biosystems), the miRNA-specific
primer/probe sets available in the miRNA Panel kit, and
RNase-free water (Promega) according to the manufac-
tuer's instructions. The separate well, 2-ΔΔ(Ct) method [45]
was used to determine relative-quantitative levels of indi-
vidual miRNAs, and these were expressed as the fold-dif-
ference to the time-matched saline treatment/challenge
group (calibrator).
Dexamethasone-mediated inhibition of LPS-induced changes  in lung tissue TNF-α, BAL fluid TNF-α and BAL neutrophils Figure 6
Dexamethasone-mediated inhibition of LPS-induced changes 
in lung tissue TNF-α, BAL fluid TNF-α and BAL neutrophils. 
Mice were pre-treated either intraperitoneally (-1 hr – A) or 
orally (-0.5 hr – B/C) with dexamethasone, then exposed to 
aerosilised LPS and at the indicated time points the tissue lev-
els of TNF-α (A) or BAL TNF-α (B) were determined by 
sandwich ELISA and inflammatory neutrophilia (C) was 
determined by differential cell counting. The values give are 
the means ± SEM obtained from 6 mice.
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Measurement of tissue TNF-α levels
Individual right lung lobes were homogenised in ice-cold
Dublecco's phosphate buffered saline (DPBS) (Sigma-
Aldrich) at a ratio of 1 ml per 100 mg tissue, using an
Ultraturrax T18 homogenizer. The homogenates were
then spun in a refrigerated (4°C) tabletop microcentrifuge
at 21,000 × g for 20 mins. The supernatants were removed
and stored at -20°C. Total protein content was deter-
mined by Bradford Assay (Bio-Rad, Hertfordshire, UK)
according to the manufacturer's instructions. Tissue TNF-
α was measured by sandwich ELISA and normalised for
total protein content.
Histology and in situ hybridisation
10 μm thick sections were cut and fixed in 4% paraformal-
dehyde (Sigma) in PBS for 10 min and then washed three
times in DPBS (2 min per wash). Sections were incubated
with 10 μg/ml proteinase K (Sigma) for 10 min at room
temperature and immediately fixed again in 4% parafor-
maldehyde. After washing three times in DPBS, sections
were pre-hybridised in hybridisation buffer (50% forma-
mide (Sigma), 5× SSC buffer (Sigma), 250 μg/ml yeast
RNA (Ambion), 1× Denhardt's solution (Sigma) in DEPC
(Sigma) treated water) for 1 hr at room temperature in a
humidifying chamber. Locked nucleic acid (LNA) probes
(miR223 or miR-scrambled) were pre-incubated at 65°C
for 5 min and immediately placed on ice. The buffer was
removed and replaced with 2 μM miRNA-specific LNA
probe or scrambled probe (Exiqon, Denmark) labelled
with digoxygenin (DIG) in hybridisation buffer and incu-
bated in a humidifying chamber at 50°C for 18 hrs. Sec-
tions were washed twice for 45 min in stringency buffer
(50% formamide, 5× SSC buffer in DEPC-treated water,
warmed to 50°C) and three times in DPBS at room tem-
perature. Sections were incubated in blocking buffer (10%
sheep serum (Sigma) in PBS) for 1 hr at room temperature
and then with sheep anti-DIG fAb fragments (Roche Diag-
nostics) labelled with alkaline phosphotase (AP) diluted
in 10% sheep serum for 2 hr at room temperature. Sec-
tions were washed three times in DPBS (2 min each) and
then incubated with AP-substrate BCIP/NBT substrate kit
(Vector Laboratories, Peterborough, UK) for 12 hrs at
room temperature in a humidifying chamber. Sections
were washed twice in DPBS and once in water and then
mounted with aqueous mounting media (DAKO, Den-
mark). Histology sections were cut at 8 μm thickness and
fixed in 95% ethanol (Sigma) for 10 minutes. Following 2
minute incubations in 75% and 50% ethanol, sections
were stained for 1 minute with 100 μl of cresyl violet
(Ambion), washed three times in water and mounted
with aqueous mounting medium. Representative images
were digitally photographed at the indicated magnifica-
tion.
Statistics
Statistical changes in cytokine expression were deter-
mined with the two-tailed student T-test with α set to 0.05
using Prism 4 for Windows (version 4.03). miRNA expres-
sion data was analysed and displayed using Genesis (ver-
sion 1.7.0) designed by Alexander Sturn and obtained
from the Institute of Genomics and Bioinformatics at the
Graz Institute of Technology. Using this software package,
hierarchical clustering (average linkage) was carried out
and significant differences were determined by analysis of
variance (ANOVA) followed by Dunn's post-test with α
set to 0.01.
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